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The fluorescent protein toolbox has revolutionized
experimental biology. Despite this advance, no
fluorescent proteins have been identified from
vertebrates, nor has chromogenic ligand-inducible
activation or clinical utility been demonstrated.
Here, we report the cloning and characterization of
UnaG, a fluorescent protein from Japanese eel.
UnaG belongs to the fatty-acid-binding protein
(FABP) family, and expression in eel is restricted to
small-diameter muscle fibers. On heterologous
expression in cell lines or mouse brain, UnaG pro-
duces oxygen-independent green fluorescence.
Remarkably, UnaG fluorescence is triggered by an
endogenous ligand, bilirubin, a membrane-perme-
able heme metabolite and clinical health biomarker.
The holoUnaG structure at 1.2 A˚ revealed a biplanar
coordination of bilirubin by reversible p-conjugation,
and we used this high-affinity and high-specificity
interaction to establish a fluorescence-based human
bilirubin assay with promising clinical utility. UnaG
will be the prototype for a versatile class of ligand-
activated fluorescent proteins, with applications in
research, medicine, and bioengineering.INTRODUCTION
The discovery of fluorescent proteins has been instrumental for
the advancement of biomedical research. In addition to
Aequorea GFPs (Tsien, 1998) and GFP-like proteins (Chudakov
et al., 2010; Miyawaki et al., 2012), near-infrared (NIR) fluores-
cent proteins developed from bacterial phytochromes have
expanded the range of experimental tools (Piatkevich et al.,
2013). Though protein engineering continues to refine the current
panel of biosensors, nature continues to remain themost reliable
source of novel fluorescent proteins. In recent years, we have1602 Cell 153, 1602–1611, June 20, 2013 ª2013 Elsevier Inc.attempted to identify fluorescent proteins with unique biological
properties lacking in known sensors. In particular, fluorescent
proteins from vertebrates are unknown to date, but their
identification could provide research tools with considerable
advantages in biological stability and utility for experimental
and medical applications compared to existing proteins from
lower organisms. Similarly, all known fluorescent proteins have
either constitutive fluorescence or covalent-bound ligands, and
there are no known proteins with diffusible chromogenic ligands
and ligand-inducible properties that could facilitate the develop-
ment of important new classes of chemical-genetic fluorescent
switches. Finally, no fluorescent proteins at present are known
to have direct practical clinical application in human health,
despite their extensive utility in biomedical research.
Unagi, the Japanese freshwater eel (Anguilla japonica), is a
historical dietary staple of Japanese cuisine. In their life cycle,
the eels travel thousands of kilometers into the open ocean to
spawn in the Philippine Sea, and the larvaemake a return journey
to freshwater habitats over several months (Tsukamoto, 2006).
This long-distance migration cycle is believed to impose consid-
erable demands on eel musculoskeletal physiology, particularly
for the maintenance of steady-state muscle homeostasis and
anaerobic oxidative metabolism during continuous swimming.
But there has been very little research on the mechanisms of
muscle metabolic physiology during travel in eels and other
long-distance migratory animals. A potential clue emerged in
2009, when it was reported that muscle fibers from unagi are
fluorescent, and fragmental amino acid sequences suggested
that the fluorescence derived from a low molecular mass protein
(Hayashi and Toda, 2009). This preliminary observation pointed
to an unexpected entry point for understanding the mechanism
of eel muscle physiology if the molecular basis of its muscle fluo-
rescence could be understood via identification of the protein.
In this study, we report the complete characterization of the
putative unagi fluorescent protein. We cloned a full-length cDNA
and showed that the corresponding polypeptide belongs to the
fatty-acid-binding protein (FABP) family (Storch and Thumser,
2000; Schaap et al., 2002; Zimmerman and Veerkamp, 2002), a
class of proteinswith known or suspected roles in oxidativemeta-
bolism. Expression of the protein we name UnaG indicates that it
Figure 1. Molecular Cloning and Heterolo-
gous Expression of an Eel Fluorescent
Protein, UnaG
(A) Amino acid sequence (single-letter code)
alignment of the protein encoded by #21(UnaG)
and human B-FABP. b-sheet-forming and a-helix-
forming regions are indicated by bars and helices,
respectively. Identical residues are shaded in gray.
Residues critical for ligand binding are shaded
in red.
(B) Differential phase-contrast (DIC) and fluores-
cence (FL) images of HeLa cells transfected with
pcDNA3 (mock), pcDNA3/EGFP, and pcDNA3/
FLAG-#21(UnaG). Scale bar, 50 mm.
(C) (Top) #21(UnaG) was fused tomCherry through
a triple repeat of Gly-Gly-Ser. (Bottom) Fluores-
cence images of a whole brain of a mouse embryo
(E16.5) at 1 day postelectroporation showing
#21(UnaG) and mCherry. See Extended Experi-
mental Procedures. Scale bar, 200 mm.
(D) Fluorescence images of HeLa cells expressing
FLAG-#21(UnaG) or EGFP during hypoxia (0.1%)
and reoxygenation (18.3%). Times (hours) post-
transfection are indicated. Scale bar, 50 mm.
(E) Fluorescence images of HeLa cells expressing
the fusion construct shown in (C) during hypoxia
(0.1%) and reoxygenation (18.3%). (Top) UnaG
fluorescence. (Bottom) mCherry fluorescence.
Scale bar, 50 mm.
See also Figure S1.does not have intrinsic fluorescence, so we conducted an exten-
sive search for the putative ligand. Surprisingly, we discovered
that the protein becomes fluorescent via noncovalent, high-
affinity, high-specificity binding to unconjugated bilirubin, the
major heme metabolite in animal physiology, a common marker
for liver function in hospital laboratories and a key indicator for
the prevalent childhood diseases of jaundice and kernicterus.
We determined the structure of holoUnaG at 1.2 A˚ and identified
the bilirubin-binding site as a biplanar p-conjugated structure
that may be useful for designing inducible fluorescent protein
switches. This unique binding fold allowed us to develop a simple,
sensitive, fluorometricmethod forquantifyingbilirubin fromhuman
clinical samples, an assay that is superior to current tests, and
thereforemayhaveglobal health care application. Together, these
studies reveal a new class of ligand-inducible fluorescent proteins
with both experimental and clinical importance and a starting
point for understanding muscle oxidative mechanisms, particu-
larly in migratory species with continuous metabolic demands.
RESULTS
Molecular Cloning of an Atypical Green Fluorescent
Protein from Eel Muscle
We searched for eel samples enriched with green fluorescence
and found that juvenile (glass) eels of Anguilla japonica wereCell 153, 1602–161strongly fluorescent (Movie S1 available
online). Complementary DNAs (cDNAs)
were synthesized from five glass eels. To
obtain a full-length clone and to establishthe identity of the putative green fluorescent protein from eel
muscle, degenerate primers were used, representing variations
in nine partial peptides whose amino acid sequences had been
determined (Hayashi and Toda, 2009). A cDNA clone encoding
a full-length protein composed of 139 amino acids was identified
(clone #21). The protein belongs to the fatty-acid-binding protein
(FABP) family (Storch and Thumser, 2000; Schaap et al., 2002;
Zimmerman and Veerkamp, 2002) with the highest homology
(56%) to brain (B-) FABP (Figure 1A). Expression of His-tagged
clone #21 in bacterial cultures did not produce fluorescence (Fig-
ures S1A and S1B), but transfection of FLAG-tagged clone #21
into culturedmammalian (HeLa) cells produced bright green fluo-
rescence comparable to that of enhanced GFP (EGFP) (Fig-
ure 1B). Robust green fluorescence of clone #21 was also
observed with intensities comparable to the red fluorescence of
a fusion partner (mCherry) in embryonic mouse brain 24 hr after
in utero electroporation on embryonic day 15.5 (Figure 1C).
Together, these results establishclone#21as thefluorescentpro-
tein from eelmuscle and show its utility as a fluorescentmarker in
living cells and in animals. We named the protein UnaG, being
from Unagi eel and emitting green fluorescence. To establish
experimental utility, the tolerance of N- and C-terminal polypep-
tide fusions to UnaG was confirmed by observing undiminished
green and red fluorescence from mCherry-UnaG and UnaG-
mCherry each expressed in cultured HeLa cells (Figure S1C).1, June 20, 2013 ª2013 Elsevier Inc. 1603
Figure 2. Bilirubin-Inducible Fluorescence
of UnaG
(A) Immediate reconstitution (fluorescence devel-
opment) of holoUnaG from apoUnaG and bilirubin
(BR). See also Movie S2.
(B) Absorption spectra of holoUnaG (green) and
bilirubin (BR) (yellow). ε, molar extinction coeffi-
cient. See also Table S1.
(C) Normalized excitation (broken line) and emis-
sion (solid line) of holoUnaG (green) and bilirubin
(BR) (yellow). See also Table S1.To further examine the fluorescence mechanism, posttrans-
fection cells were exposed to hypoxic conditions (0.1% oxygen)
for 12 hr. After transfection with pcDNA3/FLAG-#21, cells devel-
oped strong green fluorescence 4 hr after transfection, and
subsequent reoxygenation at 20 hr did not affect fluorescence
(Figure 1D, top). In contrast, cells transfected with control
pcDNA3/EGFP had faint fluorescence after a 20 hr hypoxia treat-
ment, which increased during a 2 hr reoxygenation period
(Figure 1D, bottom). Such oxygen independence of UnaG fluo-
rescence was highlighted with a fusion partner (mCherry), which
could function as an internal reference during hypoxia experi-
ments (Figure 1E). Therefore, unlike GFP, the green fluorescence
of UnaG is not limited to aerobic conditions, suggesting that
UnaG should have expansive utility in many important cell and
animal systems in which anaerobic conditions prevail and GFP
signals are not capable of being produced.
Identification of Bilirubin as the UnaG Fluorogenic
Chromophore
Given that it does not fluoresce in bacteria, we hypothesized that
UnaG required an unidentified mammalian cofactor(s) to fluo-
resce. As a member of the FABP family, we first assumed that
UnaG could form a reversible complex with a fatty acid or related
analog as its chromophore. To identify the UnaG ligand mole-
cule, we took two approaches that employed a recombinant
protein. First, FLAG-tagged UnaG expressed in HEK293 cells
was used as the holoprotein for a single-step biochemical purifi-
cation, where fluorescent holoUnaG was treated with chloro-
form/methanol for extraction of the noncovalently bound
ligand(s). We analyzed extracts in the organic phase by mass
spectrometry and identified a substance with a molecular
mass of 585.30 Da and absorption at 450 nm that was unstable,
presumably due to oxidation. Second, recombinant UnaG was
used as an apoprotein; GST-apoUnaG was purified from bac-
terial lysates, and after removal of the GST moiety, apoUnaG
was mixed with a large number of biological materials in search
for those that could induce fluorescence. The serum from most1604 Cell 153, 1602–1611, June 20, 2013 ª2013 Elsevier Inc.animals was capable of rendering the
apoprotein fluorescent (Figure S2A). Fetal
bovine serum (FBS) was the most effec-
tive among the tested sera. We fraction-
ated FBS proteins by ultracentrifugation
and identified fluorescence in fractions
containing albumin and high-density lipo-
protein (HDL) (Figure S2B). Similar resultswere obtained by using human serum (Figure S2C). Given these
results, we predicted bilirubin (BR) to be the ligand. Indeed,
addition of BR to the apoprotein resulted in immediate fluores-
cence (Figure 2A andMovie S2). HoloUnaG absorbed light maxi-
mally at 498 nm (ε498 = 77,300 M1 3 cm1) (Figure 2B); the
binding red shifted the absorption of BR by 48 nm.When excited
with blue light, holoUnaG emitted a bright green fluorescence at
527 nm (Figure 2C). The absolute fluorescence quantum yield
was determined to be 0.51 and stable at pH 4–11. The intrinsic
fluorescence of holoUnaG is greater than that of EGFP (Table
S1), suggesting that it is a stronger backbone for further genetic
optimization in the green spectral range. Together, these results
indicate that bilirubin is a fluorescent chromophore with unique
properties compared with known sensors.
Atomic Structure of HoloUnaG at 1.2 A˚ Reveals a Ligand
Interface
To study the mechanism of UnaG binding to the BR fluorogenic
chromophore, we solved the crystallographic structure of the
holoUnaG complex at 1.2 A˚ resolution (Table S2). Like other
members of the FABP family, the structure consists of 10 antipar-
allel b strands forming a b barrel that is capped by two short a
helices. BoundBR is insertedwithin the barrel in a central internal
cavity (Figure 3A). A high-resolution electron density map clearly
identifies theC5-ZC15-Z configuration (Figure 3B). The exo-vinyl
dipyrrinone moiety (rings C/D) and the B-ring propionate are
accommodated deep in the cavity, whereas the endo-vinyl
dipyrrinone moiety (rings A/B) and the C-ring propionate are
positioned near the entrance. The planar conformation is evident
when viewed from particular angles (Figure 3A, left or right),
which suggests a complete p-orbital connectivity for each dipyr-
rinone group and provides the putative structural mechanism un-
derlying the 48 nm red shift in absorption upon bilirubin binding.
BR forms many hydrogen bonds with UnaG via well-ordered
water molecules (Figure 3C). These interactions may be
compared to other FABP-ligand complexes (Figures 3D and
S3A). In human B-FABP, for example, the bound fatty acid
Figure 3. Crystal Structure of UnaG in
Complex with Bilirubin
The bilirubin (BR) chromophore is shown as a stick
representation with atoms colored (carbon, green;
oxygen, red; nitrogen, blue).
(A) Overall structure of holoUnaG viewed from
three different angles. The protein secondary
structure is shown in gray. Selected protein side
chains are shown as sticks (with carbon atoms
colored gray). N-ter, amino terminus; C-ter,
carboxyl terminus.
(B) (Left) Final refined model of the bound BR is
superimposed on the 2Fo – Fc electron density
map contoured at 2.0 s. (Right) Structure of
4Z,15Z-bilirubin-IXa, which is abbreviated to BR
or UC-BR, as necessary.
(C) Detailed view of the interactions of BRwith side
chains (with carbon atoms colored gray) of the
binding pocket. Broken yellow lines, hydrogen
bonds; cyan spheres, water molecules.
(D) Comparison of the crystal structure between
UnaG (green) and hG-FABP (magenta) with their
respective ligands, bilirubin (BR) and docosahex-
aenoic acid (DHA), respectively. Ligands and
selected side chains are highlighted in a stick
representation.
See also Figure S3.docosahexaenoic acid (DHA) forms hydrogen bonds via its
carboxylate with Arg127 and Tyr129 residues (Balendiran
et al., 2000). This hydrogen bonding is highly conserved in
many FABP-ligand interactions and may play a critical role in
ligand binding (Storch and Thumser, 2000; Schaap et al., 2002;
Zimmerman and Veerkamp, 2002). Similar hydrogen bonds are
seen in holoUnaG that involve the B-ring propionate carboxylate
and Arg132/Tyr134 residues (Figure S3A). However, the exo-
vinyl dipyrrinone moiety is buried deeper in the b barrel than
the carboxylate, and the whole BR molecule is attached to the
protein by many other hydrogen bonds. This tight coordination
of BR is a unique feature of holoUnaG compared to other
FABP holoprotein complexes and explains the high affinity and
specificity of BR binding in contrast with the lower affinities
and broader binding spectra of other FABP ligands.
Asn57 resides near the cavity entrance and interacts with the
endo-vinyl dipyrrinone moiety as well as C-ring propionate, and
its mutation generated variants that absorbed light maximally
around 500 nm but produced less (N57Q) or no (N57A) fluores-
cence emission (Figure S3B). We determined crystal structures
of these mutant holoproteins to confirm the disrupted structural
mechanism (Figure S3C).Cell 153, 1602–161High-Affinity and -Specificity
Binding of UnaG to Unconjugated
Bilirubin
In medicine, the biosynthetic form of BR
(4Z, 15Z-bilirubin IXa) is called unconju-
gated BR (UC-BR). UC-BR is a lipophilic
molecule transported in blood plasma
mostly via serum albumin to the liver,
where it is converted to BR glucuronide,also called conjugated BR (C-BR) and excreted into the bile (Fig-
ure S4). We used apoUnaG to examine the affinity and specificity
of its binding to UC-BR and determined a Kd value of 98 pM
(Figure 4A). Of note, no other BR-related compounds (Fig-
ure S4)—ditauroBR (alternative C-BR), biliverdin (BV), or
urobilin—rendered apoUnaG fluorescent (Figure 4B). These
results demonstrate the high-affinity and -specificity binding of
apoUnaG to UC-BR, consistent with the compact ligand-protein
complex revealed by the structure.
Clinical Application of ApoUnaG for Quantification
of Human Bilirubin
We examined whether UnaG could be used as a fluorescent
sensor for the clinical measurement of UC-BR, a metabolite
that is commonly associated with important health implications
such as proper liver function. UC-BR is normally present in
human blood at low concentrations, but when hemoglobin
breakdown is increased or glucuronic acid conjugation is
impaired, UC-BR accumulates in the circulation system and
extravascular tissue and may cause the pervasive childhood
diseases of jaundice and kernicterus (Wennberg et al., 2006).
An efficient diagnostic method is required that can directly1, June 20, 2013 ª2013 Elsevier Inc. 1605
Figure 4. Noncovalent, High-Affinity, High-Specificity Binding of
ApoUnaG to Unconjugated Bilirubin
(A) Titration of apoUnaG (5 nM) with unconjugated bilirubin (UC-BR).
(B) Ligand specificity of UnaG. Fluorescence intensities of 0.5 mM apoUnaG
mixed with various concentrations of UC-BR (green), ditauroBR (orange),
biliverdine (BV) (blue), and urobilin (red) were measured. Data represent the
means of three measurements.
See also Figure S4.measure serum levels of UC-BR, but current methods for UC-BR
measurement using light absorption are insensitive, indirect, and
have not changed since 1916 (Lo and Doumas, 2011). Therefore,
we reasoned that UnaG could be an ideal reagent for the design
of a new bilirubin candidate clinical test using high-resolution
fluorescence.
UC-BR exists as either a free or protein-bound form in human
serum (Table S3). As shown in Figure S2C, a large amount of UC-
BR was detected in fractions containing human serum albumin
(HSA) and only a small amount in HDL fractions. Thus, we
focused on HSA as the principal UC-BR-binding protein.
Although the crystal structure of the HSA/UC-BR complex was
determined (Zunszain et al., 2008), the binding properties are
not well understood. Also, though fluorescence of HSA/UC-BR
complex has been studied (Zucker et al., 1995; Athar et al.,
1999), it is negligibly dark compared with that of holoUnaG (Fig-
ures 5A and 5B). The affinity reported for UC-BR binding to HSA
varies greatly (Petersen et al., 2000; Weisiger et al., 2001); most
Kd values fall in a range of 10
8–106 M. We measured absorp-
tion spectra to titrate UC-BR with recombinant HSA (rHSA) and
determined the Kd to be 87 nM (Figure S5). Due to about three
orders of magnitude difference in affinity (98 pM versus
87 nM), nearly all UC-BR molecules will be bound to apoUnaG
rather than (r)HSA in an equilibrium state in which the two pro-
teins exist with similar concentrations (Figure 5C).
Considering the signal linearity that covers UC-BR concentra-
tions in hyperbilirubinemia (25 mg/dl), we constructed a fluoro-
metric method with 2 mMapoUnaG in phosphate-buffered saline
(PBS). With a 200-fold dilution of a serum sample with this solu-
tion, it is possible to accurately quantify serum levels of all forms
of UC-BR in 10 min (Figure 6A). This highly sensitive method re-
quires only a small amount of serum, is free from complicated
mathematical corrections, and is indifferent to interference,
such as hemolysis. To demonstrate the proof of principle, we
performed large-scale measurements comparing human serum
samples spiked with UC-BR (Figure 6B) and volunteer blood
samples (Figures S6A and S6B) and were able to demonstrate
the applicability of our fluorescent method while emphasizing
the limitations of conventional methodology. Due to the
simplicity, we propose that this method will be helpful to clinical
labs worldwide who run blood panels including bilirubin, and, in1606 Cell 153, 1602–1611, June 20, 2013 ª2013 Elsevier Inc.particular, pediatricians and pediatric caregivers who treat low
birth weight infants in whom high levels of UC-BR may cause
jaundice and kernicterus.
UnaG Expression in Eel Is Restricted to Small-Diameter
Muscle Fibers
The FABP family has been implicated in metabolism, including
oxidative stress homeostasis. Likewise, bilirubin has been pro-
posed to serve as an antioxidant in metabolic stress. Together,
these observations suggest that UnaG is a candidate regulatory
molecule in eel skeletal muscle metabolic physiology. However,
the biological function of UnaG binding to bilirubin and the gen-
eration of fluorescence in juvenile eel muscle remain unclear. As
the only practical entry point to this question at present, we stud-
ied the native tissue-specific expression pattern of UnaG in eel
muscle. In eels, postlarval muscle growth occurs primarily in
white muscle fibers. In transverse sections, we observed a
typical mosaic appearance in which fibers of different sizes inter-
mingled. This type of mosaic muscle hyperplasia is a particular
feature of fish that reach large final sizes (Rowlerson et al.,
1985). In juvenile Japanese eels of less than 10 cm long, we
observed green fluorescence (UnaG FL) deep in the white mus-
cle layer (Figure 7A), but not in gill, heart, liver, or digestive organs
(Figure 7B). Strikingly, within the mosaic pattern, UnaG fluores-
cencewas specifically restricted to small-diameter muscle fibers
that are generally believed to represent the most recently devel-
oped fibers during muscle growth. Notably, although small-
diameter fibers were scattered throughout the white muscle
layer, only those localized deep around the radial core of the
eel’s axis were fluorescent (Figure 7C). To determine whether
the central axial pattern of fluorescence distribution reflected
protein expression of apoUnaG or its reconstitution with bili-
rubin, we prepared an antibody (TF0231) and immunolocalized
UnaG protein (Figure 7D). Red UnaG protein immunofluores-
cence matched the UnaG green fluorescence, indicating that
UnaG exists as a holoprotein in eel muscle and that synthesis
and transport of bilirubin are efficient in the eel body. Further-
more, an in situ hybridization experiment confirmed that UnaG
mRNA was localized exclusively in small-diameter fibers (Fig-
ure 7E), which suggests that gene expression of UnaG attenu-
ates as muscles initially grow, further implicating a potential
functional role of UnaG in juvenile eel muscle metabolism.
DISCUSSION
The observation of fluorescence in muscle of the Japanese eel
has led to the discovery and characterization of UnaG, a novel
green fluorescent protein with a fundamentally different biolog-
ical source and fluorescence mechanism compared to other
known fluorescent proteins. UnaG is the first known fluorescent
protein from the vertebrate subphylum, which may endow it with
superior experimental advantages and medical applications
compared to proteins from lower organisms. UnaG is also the
first protein whose fluorescence must be activated by a natural
ligand, which we identified as unconjugated bilirubin, a lipophilic
heme metabolite, raising the possibility of designing genetically
encoded inducible fluorescent protein switches for a variety
of research applications. Moreover, the oxygen-independent
Figure 5. Preferential Interaction of UC-BR
with apoUnaG Rather Than with Recom-
binant Human Serum Albumin
(A) Absorption spectra of UC-BR (yellow); recom-
binant HSA (rHSA) complexedwith UC-BR (black);
and holoUnaG (green), which contained 10 mM
UC-BR; 10 mM UC-BR and 10 mM rHSA; and
10 mM UC-BR and 10 mM apoUnaG, respectively.
Values on the y axis are molar extinction
coefficients. See also Figure S5.
(B) Emission spectra of holoUnaG (green), UC-BR
(yellow), and rHSA complexed with UC-BR (black). (Inset) The same spectral graph with the y axis expanded 1,000 times. Although UC-BR fluorescence intensity
is enhanced when bound to serum albumin, the enhancement is negligible compared to the fluorescence of holoUnaG.
(C) We explored the possibility that all of the UC-BRmolecules are bound to added apoUnaG (2 mM) in a serum sample. Even with its moderate affinity for UC-BR,
the presence of HSA in the serum sample at a high concentration (3.4–5.4 g/dl; 0.51–0.81 mM) may trap a significant fraction of UC-BR molecules. As
hypoalbuminemia usually occurs, whereas hyperalbuminemia is rare, the concentration of HSA is assumed to be no more than 1 mM. Supposing that a serum
sample contained 1 mM HSA and an average concentration of UC-BR (10 mM), we examined the appropriate dilution of the serum sample for the effective
detection of UC-BR by 2 mMapoUnaG. A 200-fold dilution would result in 5 mMHSA and 50 nMUC-BR; the 5 mMHSA and the 2 mMapoUnaG would compete for
the 50 nM UC-BR in the reaction mixture. Taking the Kd values of HSA/UC-BR and apoUnaG/UC-BR into account, we estimated that nearly all of the UC-BR
molecules would be incorporated to generate holoUnaG. To verify this estimation, we performed a simple simulation experiment.We compared themaximal level
of UnaG fluorescence in the absence and presence of 5 mM rHSA. The fluorescence intensities reached the same level in 10 min, irrespective of the preformation
of rHSA/UC-BR complexes. These results indicated that 2 mMapoUnaGwas able to quantify the total amount of UC-BRmolecules even in the presence of (r)HSA
and that a 200-fold or greater dilution of serum samples would be suitable for the purpose.feature of UnaG will allow it to be used as the green spectral
channel in anaerobic conditions in which EGFP is inactive. The
atomic structure of UnaG revealed a molecular mechanism of
fluorescence based on reversible p conjugation. We also show
that UnaG has direct translational application as a superior
quantitative diagnostic assay that may supplant the current
global clinical standard. Finally, UnaG is efficiently expressed
in mammalian systems in vivo and will serve as a template for
the targeted development of a versatile new class of inducible
fluorescent proteins.Figure 6. Application of UnaG-Ligand Binding to Measurement of
Unconjugated Bilirubin in Human Serum Samples
(A) Ourmethod for measurement of unconjugated bilirubin (UC-BR) consists of
a 200 ml reaction mixture containing 2 mM apoUnaG (0.4 nmol) and 1 ml serum
sample (200-fold dilution) in PBS. After mixing, fluorescence intensities from
multiple samples were measured using a plate reader every 10 min. The
intensities reached their maximum levels in 10–20 min and were stable for
>1 hr. The signal stability should enable reproducible measurement of UC-BR.
It is noted that the azopigment formation or oxidation in the conventional
methods occurs gradually, and the reaction rate varies among BR species.
(B) Comparison of the fluorescent readouts of our method with the absorptive
readouts of a conventional method using bilirubin oxidase. Measured fluo-
rescence intensities were plotted as a function of the concentration of added
UC-BR to make a standard curve (red). Additionally, measured fluorescence
intensities of the human serum spiked with UC-BR were plotted against the
concentration of indirect BR, which was determined based on the oxidation
method by an outsourcing service (black). The two linear relationships
(regression equations) are very similar.
Data represent the means of three measurements. See also Figure S6.Comparison of UnaG to Current Fluorescent Proteins
The discovery and utilization of fluorescent proteins in biological
research has allowed rapid advances in many fields of biomed-
ical research in recent years. Aequorea GFPs and GFP-like
proteins, themost commonly used sensors in research, autocat-
alytically create their chromophores from amino acid side chains
(Tsien, 1998; Miyawaki et al., 2012). However, the utility of these
fluorescent proteins is limited by the requirement of molecular
oxygen for chromophore formation/maturation. Flavin mononu-
cleotide (FMN)-based fluorescent proteins (FbFPs) have also
recently been developed by engineering the blue-light-sensitive
light oxygen voltage domains (LOVs) of bacterial photoreceptors
(Drepper et al., 2007). However, because FMN is ubiquitous in
life, FbFP shows constitutive emission. Although FbFPs can be
used as fluorescent reporters in aerobic and anaerobic biological
systems, unfortunately their fluorescence is weak. It is important
to have fluorescent reporters that reliably produce signals
regardless of oxygen limitations because hypoxic or anoxic con-
ditions are commonly seen in biomedical research conditions
that involve cancer, ischemia, parasite infection, and low cellular
metabolic states. Also, optical study of microbial and other
organisms that live in anaerobic environments like the intestine
has been constrained by the lack of available oxygen-indepen-
dent green sensors.
Near-infrared (NIR) fluorescent proteins, such as IFP1.4 (Shu
et al., 2009), iRFP (Filonov et al., 2011), and Wi-Phy (Auldridge
et al., 2012), have recently been developed from bacteriophy-
tochromes, and these proteins require biliverdin for chromo-
phore development. Phytochromes—photoreceptors found in
fungi, plants, bacteria, and cyanobacteria—carry bilins (linear
tetrapyrrole compounds) as their chromophores (phytochromo-
bilins) (Rockwell et al., 2006). Also, phycobiliproteins, light-
capturing proteins found in cyanobacteria and certain algae,
utilize phycobilins as their fluorogenic chromophores (Glazer,
1989). However, because no bilin-binding proteins found in
the plant/protozoan kingdom carry unconjugated bilirubin as
a chromophore and show noncovalent binding to the ligandCell 153, 1602–1611, June 20, 2013 ª2013 Elsevier Inc. 1607
Figure 7. Natural Green Fluorescence or
UnaG Expression in Juvenile Japanese Eel
(A) Fluorescence image of a transverse section of
a formalin-fixed eel.
(B) Transverse sections at three different posi-
tions. Morphology (phase contrast) and green
fluorescence (UnaG FL) were imaged using a CCD
camera. G, gill; H, heart; L, liver.
(C) High-magnification confocal fluorescence
image of a section similar to that shown in (A) but
after staining the plasma membrane with red
fluorescence (BODIPY TR Ceramide).
(D) UnaG was immunolocalized on a transverse
section of a formalin-fixed eel. A monoclonal
antibody (TF0231) (see Extended Experimental
Procedures) raised against recombinant apoUnaG
was used. The morphology (phase contrast),
natural green fluorescence (UnaG FL), and
immunohistochemical fluorescence (UnaG IHC)
were imaged. The two fluorescence images are
merged (Merge).
(E) In situ mRNA hybridization for UnaG on a
section similar to that shown in (D).
N, notochord; SC, spinal cord; EP, epidermis.
Scale bars, 200 mm. See also Figure S7.chromophore, UnaG can be regarded as an entirely novel bilin-
binding protein.
UnaG also has distinct differences from known FABP family
members. The coordination by FABP of a heme molecule and
not the expected fatty acid represents a remarkable convergent
adaptation of evolution within the FABP family occurring after
the vertebrate radiation, suggesting that UnaG has a role in
advanced metabolism. Bilirubin binding to UnaG is positioned
deep within the barrel structure in contrast to other FABP family
members, which have shallow binding ligand pockets with broad
spectra (Figures 3D and S3A). Therefore, the high-affinity and
high-specificity binding to bilirubin also make UnaG unique
within the FABP family.
In mouse embryonic brain (Figure 1C) or cultured mammalian
cells (Figures 1D and 1E), in which UC-BR is amply produced or
supplemented, UnaG expression yields bright fluorescence in an
oxygen-independent manner. On bacterial transformation with
UnaG cDNA, there is no fluorescence (Figure S1), but subse-
quent application of exogenous bilirubin renders the trans-
formed bacteria fluorescent (Figure S1D). Therefore, in cell types
that produce no endogenous bilirubin, UnaG may be used as a
switch-like fluorogenic probe. Alternately, UnaG may be geneti-
cally engineered to bind a bilirubin chemical variant that is not
found in eukaryotic cells, permitting a unique inducible chemi-
cal-genetic fluorescent optical system. Other fluorogenic probes
have been developed that employ covalent conjugation of
ligands to protein tags (Sadhu et al., 2011). In most cases, the1608 Cell 153, 1602–1611, June 20, 2013 ª2013 Elsevier Inc.ligands are synthetic chemicals contain-
ing both chromophores and quenchers.
They remain nonfluorescent due to intra-
molecular association-induced quench-
ing until they become covalently attached
to their respective tags for spatial separa-tion of the chromophores from the quenchers. In contrast,
bilirubin is a natural chromogenic compound, which is fully
accommodated in the protein barrel of UnaG. Altogether,
UnaG will expand the conventional conception about ligand-
protein interactions of fluorescent proteins and may also extend
their research utility to inducible applications such as optical
pulse-chase experiments.
Development of a Fluorescence-Based Clinical Assay
for Bilirubin
In most clinical laboratories, bilirubin measurement is a common
test for liver function, and determining UC-BR levels in newborns
with jaundice is considered a standard medical practice. At
present, UC-BR levels in plasma/serum are quantified by a
convoluted and imprecise method involving absorptiometry of
native or derivatized tetrapyrroles. For example, during the con-
version to azoderivatives, C-BR reacts quickly with diazo
reagents (‘‘direct’’ fraction), whereas UC-BR does so slowly
(‘‘indirect fraction’’). Then total bilirubin (T-BR) is determined
after adding an accelerator of the chemical conversion reaction,
and UC-BR is calculated by subtracting C-BR from T-BR.
Identification of the UnaG ligand as UC-BR allowed us to
develop a direct fluorometric assay with potential clinical appli-
cation that is vastly superior in sensitivity, speed, reproducibility,
economy, and simplicity to currently used absorptiometric
methods. In addition, we demonstrated that apoUnaG is tolerant
to lyophilization (Figure S6C), so transportation and storage of
the assay reagent requires neither cooling nor freezing. Clinical
laboratories in remote rural areas can determine UC-BR levels
without effort; the procedure simply consists of reconstitution
of lyophilized apoUnaG with 200 ml PBS, addition of 1 ml sample,
and measurement of the fluorescence after a 10 min incubation
(Figure S6C).
It has been shown that low-nanomolar concentrations of UC-
BR can protect cells from oxidative stress (Sedlak and Snyder,
2004). Thus, future studies will include the development of
UnaG mutants with different (lower) affinities for UC-BR through
structure-guided mutagenesis and the creation of experimental
animals transgenically expressing UnaG mutants. Using these
approaches with UnaG, intravital imaging will allow unprece-
dented information about UC-BR biodistribution in tissue.
Notably, the assay using apoUnaG is not affected by hemolysis,
i.e., the presence of hemoglobin or red blood cells, and we veri-
fied measurement of UC-BR levels in blood samples (see
Extended Experimental Procedures). This property raises the
prospect that levels of circulating UC-BR in the human body
may be monitored using an apoUnaG-containing device at the
tip of a catheter. A variety of clinical evidence has accumulated
that moderately elevated serum UC-BR levels are associated
with a reduced risk of disease involving oxidative stress, such
as cardiovascular disease (Sedlak and Snyder, 2004) and dia-
betes mellitus (Fukui et al., 2008). Thus, the UnaG method using
various human samples will enhance the value of UC-BR as a
biomarker and may transform the ability of clinicians to monitor
health status in daily life. We feel that UnaG may yield insight
into the mechanistic functions of bilirubin in the body and may
thus have medical implications for understanding heme meta-
bolism in the healthy and disease states.
Implications of UnaG for Metabolism in Eel Muscle
Because larvae were first collected in the Philippine Sea,
revealing their long-range migration pattern from Japan (Tsuka-
moto, 1992), the catadromous life cycle of the Japanese fresh-
water eel has attracted significant public interest (Inoue et al.,
2010). In the current study, we show that the UnaG-bilirubin fluo-
rescent complex may serve as a new tool for experimental
biology. However, the findings may also provide an unexpected
entry point to understanding eel muscle physiology that, in turn,
could lead to more general biological insights into heme and
oxidative stress metabolism, a relatively unexplored area of
biology due to the lack of specific molecular sensors and tools,
which UnaG may now provide.
Bilirubin is known to function as a powerful physiological
antioxidant and cytoprotectant in vivo (Stocker et al., 1987;
Kapitulnik, 2004; Maines, 2005). In the oxidation-reduction
cycle, biliverdin (BV) generated by bilirubin oxidation is efficiently
reconverted to bilirubin by BV reductase, suggesting that low
levels of bilirubin may be cytoprotective (Sedlak and Snyder,
2004). The noncovalent binding of bilirubin to UnaG suggests
that this interaction may regulate the dynamic transport or
storage of free or transient pools of this metabolite, reducing
cellular oxidative stress by preserving a pool of antioxidant
molecules, which may contribute to the ability of freshwater
eels to maintain oxidative muscle metabolism during long-
distance migration in both the ocean and rivers. Moreover, it isinteresting to consider the disposition of bound bilirubin in
holoUnaG: whereas light and oxygen eventually degrade
bilirubin molecules into colorless fragments, we found that
bilirubin degradation was significantly slowed by binding to
UnaG (Figure S7A).
These findings converge with reports of the proposed
metabolic role of M-FABPs that are reported to be abundant in
the flight muscles of migratory locusts and birds (Schaap et al.,
2002; Qu et al., 2007). In this model, the FABPs are proposed
to act as both an intracellular buffer to protect cells from damage
due to excess accumulation of detergent-like fatty acids and an
intracellular fatty acid transporter to facilitate efficient fuel utiliza-
tion during sustained effort. By these mechanisms, flight
muscles may maintain high rates of fatty acid oxidation during
long airborne journeys.
Though decisive examination of this antioxidant hypothesis in
eel will require further cell-biological studies, we performed a
preliminary examination on whether UnaG fluorescence is also
observed in other species of eel that undergo long-distance
migration. We found that two other long-distance migratory
freshwater eels (Anguilla anguilla and Anguilla rostrata) also
contain bright green fluorescence in their white muscle, whereas
an oceanodromous sea eel (Conger myriaster) does not (Fig-
ure S7B). These results require follow-up studies, but it is evident
that UnaG can be used as a tool for the investigation of skeletal
muscle physiology and metabolism during endurance exercise,
with potential implications for biomedical science. We also
believe that the discovery of UnaG will open avenues to study
and conserve the biologically mysterious, economically signifi-
cant, and ecologically threatened freshwater eel.
EXPERIMENTAL PROCEDURES
Freshwater Eels
Glass eels (Anguilla japonica) were commercially obtained from a dealer
(Kenis, Osaka) in Japan. Aqua-cultured and wild-caught eels (Anguilla
japonica, Anguilla Anguilla, and Anguilla rostrata) and common Japanese
conger (Conger myriaster) were obtained from local dealers or commercial
fishermen.
cDNA Cloning and Gene Construction
Total RNA was isolated from the glass eel samples by guanidine thiocyanate
extraction. Synthesis and amplification of the fragment of interest using
degenerate primers were performed as described previously (Karasawa
et al., 2003). The full-length cDNA was generated using 50 RACE System for
rapid amplification of cDNA ends (Invitrogen) and was cloned into pT7BlueT
vector for sequence analysis. The cDNA of the coding region was amplified
using primers containing 50-BamHI and 30-EcoRI sites. The restricted product
was cloned in frame into the BamHI/EcoRI sites of pRSETB (Invitrogen) and
pGEX-2T (GE Healthcare) for bacterial expression of His-tagged UnaG and
GST-tagged UnaG, respectively. Also, the BamHI/EcoRI fragment was sub-
cloned into pcDNA3/FLAG for mammalian expression of FLAG-tagged
UnaG. pcDNA3/FLAG was constructed by inserting a sequence coding the
FLAG tag into the KpnI/BamHI sites of pcDNA3 (Invitrogen). Site-directed
mutations were introduced using GENEART Site-Directed Mutagenesis
System (Invitrogen). For synthesis of digoxigenin-labeled antisense and sense
RNA probes, the UnaG cDNA was cloned in pBlueScript (Stratagene).
HoloUnaG Protein Expression in Cultured Mammalian Cells
HEK293T or HeLa cells were grown in DMEM supplemented with 10% FBS
(GIBCO). Cells were transiently transfected with cDNA encoding FLAG-tagged
UnaG using FuGene HD (Promega). After cell lysis, protein was bound to anCell 153, 1602–1611, June 20, 2013 ª2013 Elsevier Inc. 1609
anti-FLAG M2-agarose affinity gel (Sigma), eluted with FLAG peptide (Sigma),
and concentrated using Amicon Ultra-15 (3,000 MW cut off) (Millipore); the
protein solution was loaded on a PD-10 column (GE Healthcare) for exchange
of buffer and elimination of the FLAG peptide.
Extraction of Ligand from HoloUnaG
Extraction was performed according to the method by Bligh and Dyer (1959).
Details are provided in Extended Experimental Procedures.
ApoUnaG Protein Expression in Bacteria
Proteins were expressed in Escherichia coli (BL21[DE3] or JM109[DE3]) and
purified using Ni2+ or glutathione-affinity chromatography as described
previously (Ando et al., 2002). In the latter case, UnaG protein was obtained
from GST-UnaG protein adsorbed on glutathione Sepharose 4B (GE Health-
care) by thrombin (GE Healthcare) digestion. Thrombin was eliminated from
the final sample using benzamidine Sepharose 6B (GE Healthcare). Because
GST (glutathione S-transferase) is known to be a bilirubin-binding protein
(ligandin) (Arias et al., 1980), great care was taken to exclude it. Purity of the
apoUnaG sample was checked by SDS/PAGE analysis.
Preparation of HoloUnaG from ApoUnaG and Bilirubin
Bilirubin (Wako) was dissolved in DMSO to prepare a stock solution (1 mM),
which was diluted with PBS. For preparation of holoUnaG, apoUnaG and
bilirubin were mixed with 1:2 stoichiometry in PBS containing certain con-
centrations of DMSO. Formation of holoUnaG was checked by fluorescence
development. The holoUnaG sample was applied to a PD-10 column for
elimination of DMSO and free bilirubin. As necessary, the protein sample
was concentrated using Amicon Ultra (3,000 MW cutoff).
Imaging of HoloUnaG in HeLa Cells, In Vitro Spectroscopy, and
Histology
Technical details are described in Extended Experimental Procedures.
Crystallization, X-RayDataCollection, StructureDetermination, and
Refinement
Technical details are described in Extended Experimental Procedures, and
data collection and refinement statistics are summarized in Table S2.
Measurement of Serum Levels of UC-BR
The procedure was extremely simple. PBS containing 2 mM apoUnaG was
used as the reaction solution. All measurements were done in triplicate. In
brief, 3 ml of serum was mixed with 597 ml of the reaction solution for both
200-fold dilution and reaction initiation. The reaction mixture was left standing
for at least 10 min, when reproducible results can be obtained regardless of
any additional incubation time due to the stability of the developed fluores-
cence (Figure 6A). Fluorescence emissions from mixture aliquots (200 ml
each) were measured in a 96-well microplate (Model #955900, Greiner Bio-
one) using the EnSpire Multimode Plate Reader (Perkin Elmer) with 497 nm
excitation and 527 nm emission. A PBS containing no apoUnaG was for
calibration. Because serum samples of hyperbilirubinemia were not available,
human serum (Kohjin Bio) samples spiked with various amounts of BR were
used. The same serum samples were analyzed by an outsourcing service
(Mitsubishi Chemical Medience), which employs the oxidation method to
measure direct BR ( = C – BR) and total BR for the calculation of indirect BR
( = UC – BR). Although conventional absorptiometric methods are much less
sensitive and should accordingly be intolerant of such a significant degree of
sample dilution, our fluorometric method is sensitive enough to allow a 200-
fold or more dilution. Because the diluted serum sample shows a very low
absorbance (<0.002) at the wavelength for UnaG excitation (497 nm), the inner
filter effect can be ignored. A recent study developed a fluorometric method for
quantifying free UC-BR by using amutated FABP conjugatedwith acrylodan or
rhodamine B (Huber et al., 2012). Although the mutated FABP binds to UC-BR
with a Kd value of 16 nM, the method is relatively complicated with corrections
and mathematical models. By contrast, our method takes advantage of the
ultrahigh affinity (Kd = 98 pM) of apoUnaG and simply assumes that the UC-
BR/apoUnaG complex predominates in a reaction mixture. The study using
volunteer serum samples was approved by the Ethical Committee of the1610 Cell 153, 1602–1611, June 20, 2013 ª2013 Elsevier Inc.RIKEN Safety Division. Written informed consent was obtained from the
volunteers.
ACCESSION NUMBERS
The sequence for UnaG has been deposited in the DDBJ/EMBL/GenBank
databases (accession number AB763906). Atomic coordinates and structure
factors for the reported crystal structures have been deposited with the Protein
Data Bank under accession codes 4I3B (wild-type UnaG), 4I3C (N57Q), and
4I3D (N57A).
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